Mortality from Plasmodium falciparum malaria in travelers from the United States, 1959 to 1987

Annals of Internal Medicine

Volumn 113, Issue 4, 1990, Pages 326-327

  Greenberg, Alan E ^a,c   Lobel, Hans O ^a,b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EPIDEMIOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MORTALITY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTOZOON; TRAVEL;

ADOLESCENT; ADULT; AGED; ANIMAL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN; INFANT; MALARIA; MALE; MIDDLE AGE; PLASMODIUM FALCIPARUM; TRAVEL; UNITED STATES;

EID: 0025122572     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-113-4-326     Document Type: Article

References (6)

1. Lobel HO, Campbell CC, Pappaioannou M, Huong AY. Use of prophylaxis for malaria by American travelers to Africa and Haiti. JAMA. 1989;257:2626-7.
2. Centers for Disease Control. Malaria Surveillance. Atlanta: U.S. Department of Health, Education, and Welfare; 1959-1978. U.S. Department of Health and Human Services; 1979-1987. [Annual Summaries.]
3. Lobel HO, Campbell CC, Roberts JM. Fatal malaria in U.S. civilians [Letter]. Lancet. 1985;1:873.
4. Recommendations for the prevention of malaria among travelers. MMWR. 1990;39:1-10.
5. Hoffman S. Treatment of malaria. Clin Trop Med Comm Dis. 1986; 1:225-42.
6. Miller KD, Greenberg AE, Campbell CC. Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. N Engl J Med. 1989;321:65-70.